CONTEXT: Publication of a peer reviewed study in the ASCO journal showing RWE derived mortality data and the improvements this will confer in future study design endpoints and trial patient Continue Reading
CONTEXT: Opinion piece on RWE becoming transformative in the care setting. It’s not just about pharmaceuticals, but about how we look after people holistically. IMPACT: medium READ TIME: 2 mins Continue Reading
CONTEXT: Opinion piece on RWE supporting the use of biosimilars in oncology. IMPACT: low READ TIME: 2 mins Quality Level Mean [1 – 10]: 6 1. “Providers and health care Continue Reading
CONTEXT: Report of a retrospective RWD study into the impact of race and ethnicity in oncology research. As we have reported here previously, there is an real issue with under-representation Continue Reading
RWR Insights Mental health disorders remain the highest unmet medical need, surpassing cancer. One in four of us is affected by mental illness. That’s a friend, a partner, a Continue Reading
CONTEXT: Commercial announcement of yet another RWD tie-up. IMPACT: Low READ TIME: 1 min Quality Level Mean [1 – 10]: 2 1. “FAIRFAX, Va., April 7, 2021 /PRNewswire/ Continue Reading
CONTEXT: Peer reviewed paper reviewing standard treatments for non-infectious uveitis, which is a major cause of vision loss. This data review includes analysis from both RCT and RWR studies to Continue Reading
CONTEXT: Latest update (8 April 2021) from LEEM describing the role of the QP PV | Must read! IMPACT: Medium READ TIME: 1 min Quality Level Mean [1 – 10]: Continue Reading
CONTEXT: Yet another announcement of a venture capital funded company focused on commercialising real-world data sources | Are we opening up sources or slamming the door shut unless you have Continue Reading
CONTEXT: A comprehensive summary of multiple studies | Low key press release with potentially big impact in the real world IMPACT: Medium READ TIME: 3 mins Quality Level Mean [1 Continue Reading
